Plunkett Matthew
EVP, Chief Business Officer at CELL THERAPEUTICS INC
- Sold, on record
- $1.8M
- Dollars the filings state
- Form 4 sales
- 28
- Latest Mar 4, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CELL THERAPEUTICS INCEVP, Chief Business Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CELL THERAPEUTICS INCUnusualSep 24, 2015 2015
Sold 75,869 shares at $1.57 ($119k)
Plunkett Matthew, EVP, Corporate Development
Sold 9.5% of holdings ($1.3M position)725,084 shares left6.3x usual sizeFiling
- 2 Form 4 sale CELL THERAPEUTICS INCUnusualSep 29, 2015 +5 days
Sold 75,000 shares at $1.41 ($106k)
Plunkett Matthew, EVP, Corporate Development
Sold 10.3% of holdings ($1M position)650,084 shares left6.3x usual sizeFiling
- 3 Form 4 sale CELL THERAPEUTICS INCPlan not statedOct 5, 2015 +6 days
Sold 10,000 shares at $1.52 ($15k)
Plunkett Matthew, EVP, Corporate Development
Sold 1.5% of holdings ($989k position)640,084 shares left0.8x usual sizeFiling
- 4 Form 4 sale CELL THERAPEUTICS INCPlan not statedNov 4, 2015 +30 days
Sold 10,000 shares at $1.38 ($14k)
Plunkett Matthew, EVP, Corporate Development
Sold 1.6% of holdings ($885k position)630,084 shares left0.8x usual sizeFiling
- 5 Form 4 sale CELL THERAPEUTICS INCPlan not statedDec 4, 2015 +30 days
Sold 10,000 shares at $1.00 ($10k)
Plunkett Matthew, EVP, Corporate Development
Sold 1.6% of holdings ($628k position)620,084 shares left0.8x usual sizeFiling
- 6 Form 4 sale CELL THERAPEUTICS INCPlan not statedJan 4, 2016 +31 days
Sold 10,000 shares at $1.21 ($12k)
Plunkett Matthew, EVP, Chief Business Officer
Sold 1.6% of holdings ($753k position)610,084 shares left0.8x usual sizeFiling
- 7 Form 4 sale CELL THERAPEUTICS INCPlan not statedFeb 4, 2016 +31 days
Sold 10,000 shares at $1.16 ($12k)
Plunkett Matthew, EVP, Chief Business Officer
Sold 1.6% of holdings ($705k position)600,084 shares left0.8x usual sizeFiling
- 8 Form 4 sale CELL THERAPEUTICS INCPlan not statedMar 4, 2016 +29 days
Sold 10,000 shares at $0.59 ($6k)
Plunkett Matthew, EVP, Chief Business Officer
Sold 1.7% of holdings ($355k position)590,084 shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (28)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2016 | Mar 4, 2016 | CELL THERAPEUTICS INC | EVP, Chief Business Officer | Form 4 sale | 10,000 | $6k | 1.7% | Plan not stated | SEC |
| Feb 4, 2016 | Feb 5, 2016 | CELL THERAPEUTICS INC | EVP, Chief Business Officer | Form 4 sale | 10,000 | $12k | 1.6% | Plan not stated | SEC |
| Jan 4, 2016 | Jan 6, 2016 | CELL THERAPEUTICS INC | EVP, Chief Business Officer | Form 4 sale | 10,000 | $12k | 1.6% | Plan not stated | SEC |
| Dec 4, 2015 | Dec 4, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 10,000 | $10k | 1.6% | Plan not stated | SEC |
| Nov 4, 2015 | Nov 6, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 10,000 | $14k | 1.6% | Plan not stated | SEC |
| Oct 5, 2015 | Oct 7, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 10,000 | $15k | 1.5% | Plan not stated | SEC |
| Sep 29, 2015 | Oct 1, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 75,000 | $106k | 10.3% | Unusual | SEC |
| Sep 24, 2015 | Sep 25, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 75,869 | $119k | 9.5% | Unusual | SEC |
| Sep 4, 2015 | Sep 4, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 10,000 | $15k | 1.5% | Plan not stated | SEC |
| Aug 4, 2015 | Aug 6, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 10,000 | $18k | 1.5% | Plan not stated | SEC |
| Jul 6, 2015 | Jul 8, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 10,000 | $20k | 1.4% | Plan not stated | SEC |
| Jun 4, 2015 | Jun 5, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 10,000 | $21k | 1.4% | Plan not stated | SEC |
| May 4, 2015 | May 4, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 10,000 | $19k | 1.4% | Plan not stated | SEC |
| Apr 6, 2015 | Apr 8, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 16,569 | $31k | 2.3% | Plan not stated | SEC |
| Mar 23, 2015 | Mar 24, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 59,130 | $116k | 7.5% | Unusual | SEC |
| Mar 4, 2015 | Mar 6, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $29k | 1.4% | Plan not stated | SEC |
| Feb 4, 2015 | Feb 6, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $27k | 1.4% | Plan not stated | SEC |
| Jan 5, 2015 | Jan 7, 2015 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $28k | 3.0% | Plan not stated | SEC |
| Dec 4, 2014 | Dec 5, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $27k | 2.9% | Plan not stated | SEC |
| Nov 4, 2014 | Nov 6, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $29k | 2.8% | Plan not stated | SEC |
| Oct 6, 2014 | Oct 8, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $29k | 2.7% | Plan not stated | SEC |
| Sep 23, 2014 | Sep 24, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 103,635 | $265k | 19.0% | Unusual | SEC |
| Sep 4, 2014 | Sep 5, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 27,301 | $68k | 4.8% | Plan not stated | SEC |
| Aug 4, 2014 | Aug 6, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $30k | 2.1% | Plan not stated | SEC |
| Jul 7, 2014 | Jul 9, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $35k | 2.0% | Plan not stated | SEC |
| Jun 4, 2014 | Jun 6, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $36k | 2.0% | Plan not stated | SEC |
| May 5, 2014 | May 7, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 12,000 | $36k | 1.9% | Plan not stated | SEC |
| Mar 21, 2014 | Mar 21, 2014 | CELL THERAPEUTICS INC | EVP, Corporate Development | Form 4 sale | 170,000 | $634k | 21.5% | Plan not stated | SEC |